AR042000A1 - Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados - Google Patents

Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados

Info

Publication number
AR042000A1
AR042000A1 ARP030104096A ARP030104096A AR042000A1 AR 042000 A1 AR042000 A1 AR 042000A1 AR P030104096 A ARP030104096 A AR P030104096A AR P030104096 A ARP030104096 A AR P030104096A AR 042000 A1 AR042000 A1 AR 042000A1
Authority
AR
Argentina
Prior art keywords
patients
fosinopril
dialized
cardiovascular events
reduce cardiovascular
Prior art date
Application number
ARP030104096A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR042000A1 publication Critical patent/AR042000A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)

Abstract

Uso de fosinopril o una de sus sales farmacéuticamente aceptables, para reducir el riesgo de ocurrencia de un evento cardiovascular en pacientes dializados, en donde el evento cardiovascular es una insuficiencia cardíaca, en particular en pacientes hemodializados, especialmente pacientes que presentan una hipertrofia ventricular izquierda.
ARP030104096A 2002-11-08 2003-11-07 Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados AR042000A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0214060A FR2846886A1 (fr) 2002-11-08 2002-11-08 Utilisation de fosinopril pour diminuer les evenements cardiovasculaires chez des patients dialyses

Publications (1)

Publication Number Publication Date
AR042000A1 true AR042000A1 (es) 2005-06-08

Family

ID=32116508

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104096A AR042000A1 (es) 2002-11-08 2003-11-07 Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados

Country Status (14)

Country Link
US (1) US20060135482A1 (es)
EP (1) EP1558267A1 (es)
JP (1) JP2006506405A (es)
KR (1) KR20050072480A (es)
CN (1) CN1708308A (es)
AR (1) AR042000A1 (es)
AU (1) AU2003278059A1 (es)
BR (1) BR0316059A (es)
CA (1) CA2505324A1 (es)
FR (1) FR2846886A1 (es)
MX (1) MXPA05004753A (es)
PL (1) PL374906A1 (es)
WO (1) WO2004041290A1 (es)
ZA (1) ZA200504652B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006100602A2 (en) * 2005-03-22 2006-09-28 Aurobindo Pharma Ltd Immediate release stable solid oral dosage forms op fosinopril
WO2007007686A1 (ja) * 2005-07-08 2007-01-18 Mochida Pharmaceutical Co., Ltd. 心血管イベント発症予防用組成物
US20070087975A1 (en) * 2005-10-17 2007-04-19 Sigma-Tau Industrie Farmaceutiche Riunite Spa Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
SI23149A (sl) * 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931464A (en) * 1989-02-15 1990-06-05 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
WO2003013434A2 (en) * 2001-08-06 2003-02-20 Genomed, Llc Methods and compositions for treating diseases associated with excesses in ace
AU2003214079B2 (en) * 2002-02-28 2007-05-31 Novartis Ag N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents

Also Published As

Publication number Publication date
KR20050072480A (ko) 2005-07-11
CA2505324A1 (en) 2004-05-21
FR2846886A1 (fr) 2004-05-14
WO2004041290A1 (en) 2004-05-21
US20060135482A1 (en) 2006-06-22
JP2006506405A (ja) 2006-02-23
BR0316059A (pt) 2005-09-27
ZA200504652B (en) 2006-03-29
PL374906A1 (en) 2005-11-14
EP1558267A1 (en) 2005-08-03
AU2003278059A1 (en) 2004-06-07
MXPA05004753A (es) 2005-08-02
CN1708308A (zh) 2005-12-14

Similar Documents

Publication Publication Date Title
AR087241A2 (es) Derivados de 6-oh-4h-benzo[1,4]oxazin-3-ona para el tratamiento de la enfermedad pulmonar obstructiva cronica
NO20044436L (no) Substituerte fenyleddiksyrer
AR018717A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA, SU USO, UN PROCESO PARA SU PREPARACIoN, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, Y COMPUESTOS INTERMEDIARIOS.
AR048588A1 (es) Uso de inhibidores de la fosfodiesterasa de tipo iii (pde iii) para la reduccion del tamano del corazon en mamiferos que padecen insuficiencia cardiaca
MXPA03006855A (es) Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion.
BR0209948A (pt) Inibidores de fator inibitório de migração de macrófago e métodos para identificar os mesmos
NO20060416L (no) Ny anvendelse I
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
BRPI0413695A (pt) derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas
UY27518A1 (es) Nuevos derivados de pirrolidina
BR0307590A (pt) Laminado
IS8230A (is) Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
SV2004001756A (es) Nueva difenilazetidinona con propiedades fisiologicas mejoraradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso
AR109263A2 (es) Composición que comprende moxidectina
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
AR039633A2 (es) Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
DK1377164T3 (da) Erythropoietin forbedrer kemoterapi-induceret toksicitet in vivo
AR111374A1 (es) Uso de lik066 en pacientes con insuficiencia cardíaca
ECSP10010464A (es) Uso de ranolazina para el tratamiento de enfermedades cardiovasculares
AR042000A1 (es) Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados
CR9073A (es) Coadministracion de tigeciclina y digoxin
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
ES2133390T3 (es) Derivados de triazolopirimidinas antagonistas de los receptores de la angiotensina ii.
UY27910A1 (es) Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca

Legal Events

Date Code Title Description
FB Suspension of granting procedure